Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach™ is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.
Latest news All news
Anatara Lifesciences is pleased to announce the appointment of two new members to its executive management team, and strengthens the board with a new non-executive director.
Please click here to view the announcement.
Anatara Lifesciences has released its Appendix 4D Interim Financial Report, for the Half Year ended 31 December 2014, to the market today.
Please click here to view the ASX announcement.